Literature DB >> 6113287

The influence of neonatal orchiopexy upon the testis in persistent Müllerian duct syndrome.

A Melman, E Leiter, J M Perez, D Driscoll, C Palmer.   

Abstract

We report on a patient with persistent müllerian duct syndrome and normal external genitalia who had embryonal cancer of the testis 16 years after neonatal bilateral orchiopexy. In previous cases the testes of these patients have not been considered predisposed to form tumors. However, the occurrence of a testis tumor has been reported in 8 patients with this syndrome. The specific factors resulting in tumor formation in such patients are uncertain. Until they are clarified we suggest that these patients should be observed carefully for the possible development of testis tumor.

Entities:  

Mesh:

Year:  1981        PMID: 6113287     DOI: 10.1016/s0022-5347(17)55233-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Laparoscopic orchidopexy for persistent müllerian duct syndrome.

Authors:  J W Ng; G H Koh
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

2.  Persistent Mullerian duct syndrome with transverse testicular ectopia and seminoma.

Authors:  Bilal Fırat Alp; Zafer Demirer; Ali Gürağaç; Oğuzhan Babacan; Erkan Sarı; Sebahattin Sarı; Ibrahim Yavan
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

3.  A single base pair mutation encoding a premature stop codon in the MIS type II receptor is responsible for canine persistent Müllerian duct syndrome.

Authors:  Xiufeng Wu; Shengqin Wan; Shashikant Pujar; Mark E Haskins; Donald H Schlafer; Mary M Lee; Vicki N Meyers-Wallen
Journal:  J Androl       Date:  2008-08-21

Review 4.  Transverse testicular ectopia, a case report and review of literature.

Authors:  Mohammad Kazem Moslemi; Mohammad Reza Ebadzadeh; Shabir Al-Mousawi
Journal:  Ger Med Sci       Date:  2011-07-07

5.  Persistent Müllerian duct syndrome: A case report and review.

Authors:  Xiaoya Ren; Di Wu; Chunxiu Gong
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.